信義光能(00968.HK)上半年純利跌58.8%至7.458億元 中期息4.2港仙
格隆匯8月1日丨信義光能(00968.HK)公佈中期業績,截至2025年6月30日止六個月,公司收益爲人民幣109.318億元,同比減少6.5%;公司權益持有人應佔溢利爲人民幣7.458億元,同比減少58.8%;基本每股盈利爲人民幣8.21分,擬派每股中期股息4.2港仙。
2025年上半年的收益主要來自兩個核心業務分部,即太陽能玻璃銷售及太陽能發電場業務。儘管銷量持續增長,太陽能玻璃分部的收入仍有所下降,主因市場供求失衡導致銷售價格同比大幅下跌。與此同時,太陽能發電場業務的銷售收入則錄得輕微增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.